Boston Scientific Corporation (LON: 0HOY)
London
· Delayed Price · Currency is GBP · Price in USD
100.58
-0.67 (-0.66%)
Jan 23, 2025, 2:42 PM BST
Boston Scientific Revenue
Boston Scientific had revenue of $4.21B USD in the quarter ending September 30, 2024, with 19.34% growth. This brings the company's revenue in the last twelve months to $15.91B, up 15.66% year-over-year. In the year 2023, Boston Scientific had annual revenue of $14.24B with 12.29% growth.
Revenue (ttm)
$15.91B
Revenue Growth
+15.66%
P/S Ratio
n/a
Revenue / Employee
$331.48K
Employees
48,000
Market Cap
120.04B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 14.24B | 1.56B | 12.29% |
Dec 31, 2022 | 12.68B | 794.00M | 6.68% |
Dec 31, 2021 | 11.89B | 1.98B | 19.92% |
Dec 31, 2020 | 9.91B | -822.00M | -7.66% |
Dec 31, 2019 | 10.74B | 912.00M | 9.28% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 38.20B |
GSK plc | 31.31B |
Haleon | 11.24B |
Smith & Nephew | 4.46B |
ConvaTec Group | 1.74B |
Hikma Pharmaceuticals | 2.39B |
HUTCHMED (China) | 483.31M |
Oxford Nanopore Technologies | 167.75M |
Boston Scientific News
- 2 days ago - Top 4 Health Care Stocks You May Want To Dump In Q1 - Benzinga
- 6 days ago - Boston Scientific (BSX) Receives Preliminary Approval for Shareholder Derivative Settlement - GuruFocus
- 6 days ago - Late-breaking data presented at AF Symposium 2025 highlight key Boston Scientific therapies for management of patients with atrial fibrillation - PRNewsWire
- 8 days ago - Boston Scientific Jumps Ahead of Earnings - FX Empire
- 8 days ago - Boston Scientific Standing Apart As A Rare Med-Tech Growth Story - Seeking Alpha
- 9 days ago - We have the largest venture portfolio in medtech, says Boston Scientific CEO Mike Mahoney - CNBC
- 12 days ago - Stocks on the move: Delta, Constellation Energy, Wynn, Sweetgreen and Boston Scientific - CNBC
- 14 days ago - Boston Scientific Completes Acquisition of Bolt Medical, Bolstering Cardiovascular Portfolio - GuruFocus